US biotech firm Novavax's COVID-19 vaccine was shown to be 100 percent protective against severe cases of the disease, including hospitalization and death, the company said Thursday following trials.
Mar 12, 2021
0
4
French pharmaceutical firm Sanofi on Friday announced the launch of human trials of its second COVID-19 vaccine, with its first still in the testing phase after having fallen behind in development.
Mar 12, 2021
0
2
More than 50 million Americans have received at least one dose of either the Pfizer or Moderna COVID-19 vaccine. So far, Americans have been largely brand-agnostic, but that's about to change as a new vaccine rolls out.
Mar 8, 2021
0
7
Scientists at Walter Reed Army Institute of Research, in a collaboration the Duke University, have confirmed that monoclonal antibodies can be an effective tool in the global fight against malaria.
Mar 5, 2021
2
30
The United States' drug regulator, the Food and Drug Administration (FDA), said last week COVID vaccines updated for variants won't need to go through full randomized controlled clinical trials.
Mar 5, 2021
0
4
Americans love to have choices, and now there are three COVID-19 vaccines approved for use in the United States.
Mar 5, 2021
0
5
A Cuban-developed coronavirus candidate vaccine entered into Phase III trials Thursday, the first shot developed by a Latin American country to get this far, the government said.
Mar 4, 2021
0
2
As a middling but competent clinician-scientist, I feel desperately sorry for the general public trying to make head or tail of some of the scientific discussions on the pandemic right now.
Mar 2, 2021
0
5
US biotech company Novavax said Monday it hopes to file for British approval of its COVID-19 vaccine at the start of the second quarter of 2021, and to do the same soon after in the United States.
Mar 2, 2021
0
3
The plane laden with vaccines had just rolled to a stop at Santiago's airport in late January, and Chile's president, Sebastián Piñera, was beaming. "Today," he said, "is a day of joy, emotion and hope."
Mar 2, 2021
0
1
